Anandamide Tolerance Developed Without Reduced Receptor Binding in Rats

Rats developed behavioral tolerance to repeated anandamide while cannabinoid receptor binding remained unchanged in the regions tested. Reduced agonist-stimulated G protein responses pointed instead toward functional desensitization under this regimen.

The administered compound was endogenous but experimentally dosed

Anandamide is an endogenous cannabinoid, but the experiment administered it by injection over 15 days. This is different from observing ordinary endogenous fluctuations or exposing animals to THC. The investigators examined the striatum, cortex, hippocampus and cerebellum.

Binding and function separated

Receptor binding did not change in the sampled regions, while agonist-stimulated GTP-binding responses fell substantially. Preserved receptor binding therefore did not mean preserved responsiveness. Conversely, the experiment did not support receptor downregulation as the necessary explanation for the observed behavioral tolerance.

The cAMP findings were null

The researchers also detected no change in cAMP levels or PKA activity in the examined regions. Their proposed explanation emphasized receptor desensitization rather than changes at every measured signaling level. Those null results apply to the protocol and assays, rather than excluding all possible downstream adaptations.

This study shows why tolerance should not be reduced to receptor number alone. It does not establish that anandamide and THC produce identical adaptations, or that unchanged binding proves an absence of drug effects. The specific ligand, functional assay and behavioral outcome define what the result can support.

Related: interpreting cannabis tolerance claims.

Research cited

Rubino T; Viganò D; Costa B; Colleoni M; Parolaro D. Loss of cannabinoid-stimulated guanosine 5'-O-(3-[(35)S]Thiotriphosphate) binding without receptor down-regulation in brain regions of anandamide-tolerant rats. Journal of neurochemistry (2000). doi:10.1046/j.1471-4159.2000.0752478.x. Findings discussed from the study abstract.

Spread the love


The National Black Lawyers

top 40 lawyers

civil trial law

Lawyers of Distinction

Loading...

Recent Blog Articles

Acute THC Altered Adrenal Catecholamine Stores Without a Matching Enzyme Decline

An experimental THC study found lower adrenal-medullary catecholamine stores after acute exposure without a statistically significant decline in a key synthesis enzyme. The changes disappeared with repeated treatment, while circulating hormones followed partly different patterns. Tissue content and enzyme activity were separate measures Acute THC decreased adrenal norepinephrine and epinephrine…

Spread the love

Read Article: Acute THC Altered Adrenal Catecholamine Stores Without a Matching Enzyme Decline

Rimonabant Analogues Produced Cannabinoid-Like Mouse Behaviors Without THC-Like Drug Cues

Some experimental rimonabant analogues produced cannabinoid-like effects in mouse tests but did not reproduce THC's learned drug cue. Other comparisons also separated the compounds from THC, cautioning against equating a similar outward profile with the same pharmacology. Behavioral similarity was only the starting point O-6629 and O-6658 produced dose-dependent effects…

Spread the love

Read Article: Rimonabant Analogues Produced Cannabinoid-Like Mouse Behaviors Without THC-Like Drug Cues

Whole-Brain Receptor Assays Stayed Unchanged Despite Marked THC Behavioral Tolerance in Mice

A mouse study detected substantial THC behavioral tolerance without significant changes in whole-brain receptor binding or mRNA. The result limits a simple whole-brain explanation while leaving regional or functional changes unresolved. Behavior and biochemical assays were different endpoints Mice received THC twice daily for six and a half days. Testing…

Spread the love

Read Article: Whole-Brain Receptor Assays Stayed Unchanged Despite Marked THC Behavioral Tolerance in Mice

Speak with an expert today!

Contact the offices of Okorie Okorocha for professional and reliable advice which you can trust.

Call (424) 363-3347 Contact Us